Nemolizumab in moderate to severe atopic dermatitis: An exploratory analysis of work productivity and activity impairment in a randomized phase II study

Ryosuke Mihara, Kenji Kabashima, Masutaka Furue, Miwa Nakano, Thomas Ruzicka

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Nemolizumab in moderate to severe atopic dermatitis: An exploratory analysis of work productivity and activity impairment in a randomized phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences